Concepedia

Tawfik Gharbaoui

TG

Statistics

Publications

20

Citations

707

H-Index

15

Active since

1992

Affiliations

Arena Pharmaceuticals (United States)(Current)

Centre National de la Recherche Scientifique

Mirati Therapeutics (United States)

Institut de Chimie des Substances Naturelles

Institut Curie

Tawfik Gharbaoui is an author at Arena Pharmaceuticals (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1992–2023

20

Publications

20

3-(1<i>H</i>-Tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): A Partial Agonist of the Nicotinic Acid Receptor, G-Protein Coupled Receptor 109a, with Antilipolytic but No Vasodilatory Activity in Mice

Graeme Semple, Philip J. Skinner, Tawfik Gharbaoui et al. · Journal of Medicinal Chemistry · 2008 · 96 citations · Full text

, , +14

Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor

Daniel J. Buzard, Sun Hee Kim, Luis Lopez et al. · ACS Medicinal Chemistry Letters · 2014 · 72 citations · Full text

, , +17

Discovery of fused bicyclic agonists of the orphan G-protein coupled receptor GPR119 with in vivo activity in rodent models of glucose control

Graeme Semple, Albert Ren, Beatriz Fioravanti et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 67 citations · Full text

, , +15

Analogues of Acifran:  Agonists of the High and Low Affinity Niacin Receptors, GPR109a and GPR109b

Jae‐Kyu Jung, Benjamin Johnson, Tracy Duong et al. · Journal of Medicinal Chemistry · 2007 · 56 citations · Full text

, , +16

Discovery of Selective Phosphodiesterase 1 Inhibitors with Memory Enhancing Properties

Brian Dyck, Bryan J. Branstetter, Tawfik Gharbaoui et al. · Journal of Medicinal Chemistry · 2017 · 56 citations · Full text

, , +14

1–5 of 20